In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA reiterates warning against bovine-derived materials in cosmetics in May 9 letter.

This article was originally published in The Rose Sheet

Executive Summary

FDA REITERATES WARNING AGAINST USE OF BOVINE-DERIVED MATERIALS IN COSMETICS in a May 9 letter issued by FDA Deputy Commissioner for Operations Michael Friedman. The letter, which was sent to the Cosmetic, Toiletry and Fragrance Association and the Independent Cosmetic Manufacturers & Distributors Association, emphasizes that cosmetic companies should "take whatever steps are necessary to assure...that such ingredients do not come from cattle born, raised, or slaughtered in countries where BSE exists." The letter cites the U.S. Department of Agriculture's current list of BSE countries -- Great Britain, Switzerland, France, the Republic of Ireland, Oman and Portugal.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002821

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel